You are here

Heart Failure


Patients who suffer brain damage after cardiac arrest could benefit from magnetic resonance (MR) imaging following their stabilization—a measure that has been shown to predict clinical outcomes through mapping brain activity, according to new research published in the American journal Radiology.

Ventricular assist devices (VADs) foster improved survival for children awaiting heart transplantation when compared to the current standard of extracorporeal membrane oxygenation (ECMO), according to a new study in the Journal of the American College of Cardiology.

African Americans are dying an average of 3.4 years before white Americans, a significant gap that’s attributable to more prevalent cardiovascular disease (CVD) and risk factors in the black population, the American Heart Association (AHA) reported in a scientific statement published Monday in Circulation.

Cardiovascular research has traditionally focused on hard clinical endpoints such as markers of disease progression, adverse events and death. But now researchers are calling for more studies that incorporate the viewpoints of patients and caregivers, both in trial design and execution and in measuring outcomes like quality of life, time off work, out-of-pocket expense and caregiver burden.

Digital tracking devices can motivate patients to increase their physical activity outside of structured cardiac rehabilitation, a new study suggests.


Recent Headlines

AHA, Bayer offer grant program for research on heart failure, other conditions

The American Heart Association (AHA) and Germany-based Bayer have announced a collaboration to complete research on cerebral small vessel disease, chronic kidney disease and heart failure.

MRI helps researchers find disparities in different forms of heart failure

Researchers at the University of Texas at Arlington have created a way to measure oxygen consumption in the legs of heart failure patients using MRI, a finding that sheds light on the intricacies of different forms of heart failure.

CMS convenes panel, invites comments on health outcomes for heart failure treatment technologies

The Centers for Medicare & Medicaid Services (CMS) will convene a panel of experts on March 22 at a public meeting in Baltimore.

Penn researchers discover proteins that could prevent heart failure after heart attack

Researchers from the University of Pennsylvania have discovered new evidence that could help explain why patients who’ve suffered heart attacks go into heart failure.

Metformin may reduce all-cause mortality in patients with congestive heart failure

A systematic review of 17 observational studies found that metformin was associated with a reduction in all-cause mortality in patients with type 2 diabetes and chronic kidney disease, congestive heart failure or chronic liver disease with hepatic impairment.

Medical community worried Americans face increased risk of heart disease

As the number of Americans diagnosed with high blood pressure continues to rise, the medical community is growing increasingly worried about the population’s risk of having heart attacks, said the American Academy of Family Physicians in a Feb. 2 statement.

Certain pain relievers may increase risk for heart attack during cold, flu

Though many people take pain relievers to ease a sore throat or headache when enduring the flu or a cold, new research says doing so could increase the risk of suffering a heart attack.

Researchers find new method to determine blood clot risks

Predicting when a patient is at risk for developing a blood clot can be challenging for physicians, but new research from Johns Hopkins University and Ohio State University delivers a method for precisely identifying those risk factors.

Heart failure expected to steadily rise through 2030

New statistics show the number of people diagnosed with heart failure will rise 46 percent by 2030, a major increase that would result in more than eight million people to be diagnosed with the condition, according to a new report from the American Heart Association.

Tackling Intolerance: What to Do When Patients Pull the Plug on Statins

Despite their well-documented benefits, statins are often discontinued by patients because of their equally acknowledged side effects. This has continued to fuel heated debate over how widespread—or even legitimate—these adverse events are, whether physicians give up too easily on patients who are statin intolerant and what other options exist for patients who could gain by taking their cholesterol-lowering medicine?